Vascular Research Laboratory, Providence VA Medical Center, 830 Chalkstone Ave., Providence, RI 02908, USA.
J Nucl Cardiol. 2010 Jan-Feb;17(1):45-51. doi: 10.1007/s12350-009-9158-x.
Individuals with normal myocardial perfusion imaging (MPI) may still have substantial coronary artery disease (CAD), which would benefit from aggressive medical therapy. The role of coronary artery calcium-score (CAC) and/or coronary CT Angiography (CTA) to identify additional treatment candidates in this population is unknown.
Ninety-four patients completed the study protocol and underwent CAC and CTA after MPI.
In 81 patients who had a normal MPI, an algorithm using the clinical predictors, CAC, and then CTA was created to identify candidates for aggressive medical management; 24/81 patients had a high Framingham Risk Score (FRS) or diabetes, and need aggressive medical management, while 6/81 patients had a low FRS and low post-MPI probability of CAD. The use of CAC in 51/81 patients with intermediate clinical predictors would identify 23/51 patients with low risk (CAC < 100) and 11/51 patients (CAC > 400) for aggressive medical management. The remaining 17/51 patients with intermediate CAC scores (100-399) would require CTA, of which, would identify 8/17 additional patients with >50% stenosis for aggressive medical therapy.
A stepwise approach including history, CAC and CTA can identify about 50% of the patients with normal MPI who have a higher risk and may benefit from aggressive medical management.
心肌灌注成像(MPI)正常的个体可能仍存在大量的冠状动脉疾病(CAD),这将受益于积极的药物治疗。在该人群中,冠状动脉钙评分(CAC)和/或冠状动脉 CT 血管造影(CTA)来确定额外治疗候选者的作用尚不清楚。
94 名患者完成了研究方案,并在 MPI 后接受了 CAC 和 CTA。
在 81 名 MPI 正常的患者中,创建了一个使用临床预测因子、CAC 然后 CTA 的算法,以确定积极药物管理的候选者;24/81 名患者具有高弗雷明汉风险评分(FRS)或糖尿病,需要积极的药物治疗,而 6/81 名患者具有低 FRS 和低 MPI 后 CAD 概率。在 51/81 名具有中等临床预测因子的患者中使用 CAC 将确定 23/51 名低风险(CAC<100)和 11/51 名(CAC>400)的患者需要积极的药物治疗。剩余的 17/51 名 CAC 评分中等(100-399)的患者需要 CTA,其中将确定 8/17 名患有>50%狭窄的患者需要进行积极的药物治疗。
包括病史、CAC 和 CTA 的逐步方法可以确定约 50%的 MPI 正常的患者具有更高的风险,并且可能受益于积极的药物治疗。